Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”

Joshua R Ehrlich, Sayoko E MoroiDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USAWe read with great interest the article by Patodia et al entitled, “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ehrlich JR, Moroi SE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/33bba81e9c484825b0b5d9b3cc5b99a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:33bba81e9c484825b0b5d9b3cc5b99a8
record_format dspace
spelling oai:doaj.org-article:33bba81e9c484825b0b5d9b3cc5b99a82021-12-02T06:25:23ZComment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”1177-5483https://doaj.org/article/33bba81e9c484825b0b5d9b3cc5b99a82017-06-01T00:00:00Zhttps://www.dovepress.com/comment-on-clinical-effectiveness-of-currently-available-low-vision-de-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Joshua R Ehrlich, Sayoko E MoroiDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USAWe read with great interest the article by Patodia et al entitled, “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.”1 The authors presented a pilot randomized controlled trial (RCT) in which subjects with glaucoma and low vision were assigned to observation or to receive standard low vision device(s). Using the Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48), the researchers found an improvement in reading ability and overall visual ability among those allocated to treatment compared to the control arm.The authors correctly note that this is the first RCT to examine the effectiveness of low vision services for patients with glaucoma. In fact, there is also no rigorous evidence for the effectiveness of low vision interventions for patients with other causes of peripheral field loss (PFL) such as retinitis pigmentosa, hemianopia, or dense pan- retinal photogoagulation;2 this lack of evidence is concerning since around one-fifth of patients with low vision have been found to have significant PFL.3 Patodia et al1 point out that different patterns of functional impairment are likely to result from central and peripheral vision loss. Although this has been corroborated by prior research, there is still an inadequate qualitative understanding of how PFL affects patients’ day-to-day lives and how this is impacted by demographic and sociological features such as age, gender, culture, and place.View the original paper by Patodia et al.Ehrlich JRMoroi SEDove Medical PressarticleGlaucomaLow VisionRehabilitationPatient-Reported OutcomesMixed MethodsOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 1119-1120 (2017)
institution DOAJ
collection DOAJ
language EN
topic Glaucoma
Low Vision
Rehabilitation
Patient-Reported Outcomes
Mixed Methods
Ophthalmology
RE1-994
spellingShingle Glaucoma
Low Vision
Rehabilitation
Patient-Reported Outcomes
Mixed Methods
Ophthalmology
RE1-994
Ehrlich JR
Moroi SE
Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
description Joshua R Ehrlich, Sayoko E MoroiDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USAWe read with great interest the article by Patodia et al entitled, “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.”1 The authors presented a pilot randomized controlled trial (RCT) in which subjects with glaucoma and low vision were assigned to observation or to receive standard low vision device(s). Using the Veterans Affairs Low Vision Visual Functioning Questionnaire (VA LV VFQ-48), the researchers found an improvement in reading ability and overall visual ability among those allocated to treatment compared to the control arm.The authors correctly note that this is the first RCT to examine the effectiveness of low vision services for patients with glaucoma. In fact, there is also no rigorous evidence for the effectiveness of low vision interventions for patients with other causes of peripheral field loss (PFL) such as retinitis pigmentosa, hemianopia, or dense pan- retinal photogoagulation;2 this lack of evidence is concerning since around one-fifth of patients with low vision have been found to have significant PFL.3 Patodia et al1 point out that different patterns of functional impairment are likely to result from central and peripheral vision loss. Although this has been corroborated by prior research, there is still an inadequate qualitative understanding of how PFL affects patients’ day-to-day lives and how this is impacted by demographic and sociological features such as age, gender, culture, and place.View the original paper by Patodia et al.
format article
author Ehrlich JR
Moroi SE
author_facet Ehrlich JR
Moroi SE
author_sort Ehrlich JR
title Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
title_short Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
title_full Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
title_fullStr Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
title_full_unstemmed Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
title_sort comment on “clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/33bba81e9c484825b0b5d9b3cc5b99a8
work_keys_str_mv AT ehrlichjr commentonldquoclinicaleffectivenessofcurrentlyavailablelowvisiondevicesinglaucomapatientswithmoderatetoseverevisionlossrdquo
AT moroise commentonldquoclinicaleffectivenessofcurrentlyavailablelowvisiondevicesinglaucomapatientswithmoderatetoseverevisionlossrdquo
_version_ 1718399925879832576